Introduction
The Notch signalling system is conserved from Drosophila to humans and regulates cell differentiation, proliferation and survival. Notch pathways play an important role in embryonic development, T-cell development and function, and in disease processes including carcinogenesis and autoimmunity. In mammals there are four Notch receptors (1 to 4) and five Notch ligands (Jagged-1, Jagged-2, Delta-like 1 (DL-1), DL-3 and DL-4) [1].
Notch proteins exert their pleiotropic effects through the regulation of expression of various downstream genes, many of which require the interaction of Notch proteins with the DNA binding transcription factor CSL in order to form a short-lived nuclear transcription complex [2] . After engagement with its ligands, successive proteolytic events cause clipping of the Notch protein. The first is mediated by ADAM proteases and the second by the γ-secretase complex, in which presenilins (PS1 and PS2) constitute the active center of the enzyme complex. These proteolytic events ultimately release the intracellular domain of Notch (NICD). The formation of a complex of activated intracellular Notch protein and CSL converts CSL from a transcriptional repressor to a transcriptional transactivator. The genes encoding the HES (hairy and enhancer of split) family of basic helix-loop-helix proteins are Notch targets that are known to be essential for T-cell development and signalling.
In addition to influencing Th1-and Th2-cell differentiation [3] , Notch signalling has also been involved in the differentiation and expansion of regulatory T (Treg) cells [4] . Several reports have shown that the presence of Notch ligands, mostly of the Jagged family, can enhance Treg-cell differentiation and function in vitro [5] . For example, exposure of Treg cells to Jagged-2 expressed by hematopoietic progenitor cells has been shown to modulate peripheral Treg-cell expansion and prevents the development of diabetes in an autoimmune disease mice model [6] . Transgenic mice over expressing the active intra-cellular form of Notch3 exhibit an increased percentage of Treg cells and are refractory to the induction of experimental autoimmune diabetes when treated with streptozotocin [7] . Moreover, there is emerging data suggesting that Notch can crosstalk or cooperate with other signalling pathways and thereby broaden the spectrum of target genes that are influenced by Notch signalling. For example, the interaction of Notch and TGF-β signal pathways plays a role in Treg-cell effector function through a modulation of FoxP3 expression or by facilitating TGF-β mediated suppressive function of Treg cells [8, 9] . For example, Asano et al showed that
Treg cells express Notch ligands and also that Notch signaling plays an important role on effector function of TGF-β and its signaling through an interaction of NICD and Smad 3 [9] . Therefore, most of the reports focused on the influence of Notch signalling on Treg cells.
Here, we hypothesized that Notch signalling modulates the response of effector T cells to Treg cell-mediated suppressive effects. We show that Notch activation through its ligands increases exquisitely the sensitivity of effector CD4 + T cells to the suppressive effect of Treg cells even at low frequency. This effect is mediated through an upregulation of TGF-βRII and the phosphorylated form of Smad 3 protein on effectors T cells. We show that HES-1 transactivates the TGF-βRII promoter. Exposure of Treg cells to DL-1, DL-4 or Jagged-1 did not modify the Treg-cell capacity to suppress CD4 + CD25 -proliferation in the presence of anti-CD3 mAbs (Fig 2A) . In contrast, initiation of Notch signalling in CD4 + CD25 -following exposure to DL-1, DL-4 or Jagged-1 increased significantly their sensitivity to Treg cell-mediated suppression in 5-days coculture experiments in the presence of anti-CD3 ( Fig 2B) . As shown in figure 2C , percentages of Anti-TGF-β (2.5µg/ml) or isotype control mAbs were added at the beginning of the culture.
Results

Notch1 signaling is involved in Treg cell-mediated suppression
Coculture experiments performed in the presence of either DL-4 or Jagged-1 led to a mean inhibition of T cell proliferation of 47% and 65%, respectively as compared to 12% when cells were pre-treated with IgG control. As shown in figure 3A , these percentages became with Notch ligands or IgG control in the presence of TGF-β (5ng/ml). We then performed immunoblot to assess the expression of pSmad3, a major TGF-β signalling intermediate [11] .
As shown in figure 4A , DL-4 and Jagged-1 exposure induced pSmad3 expression, while only a weak pSmad3 band was detected in IgG control and DL-1 stimulated cells. Western blot analysis showed that TGF-β induced a significant increase of pSmad3 expression in To explore the mechanism by which Notch may regulate TGF-βRII expression, we have performed transactivation experiments. Since these experiments cannot be performed easily on primary CD4 + T cells, we used rat PC12, a cell line widely used to explore the role of HES-1 as a modulator of cell differentiation and proliferation [12] . We analyzed the transactivation of the TGF-βRII promoter by wtHes-1 (pCI-HES-1) or a DN mutant (dnHES-1). In three separate experiments, we found that wtHES-1 induced a strong transactivation of the TGF-ßRII luciferase reporter promoter containing 5' sequences compared with transfection with the empty vector ( figure 4C ). No increase in luciferase activity was seen when wtHES-1 and dnHES-1 were cotransfected. Interestingly, when transfected alone, the dnHES-1 plasmid decreased luciferase activity below that measured with the empty vector, since it neutralized endogeneous HES-1 activity on the TGF-ßRII reporter promoter. These results demonstrated that HES-1 activates the TGF-ßRII promoter through its DNA-binding activity.
Discussion
Although, Treg cells mediate their suppressive effects through different mechanisms, it is well established that Treg cells produce or express at their surface TGF-β, which participates to their suppressive effects [13] [14] [15] . In the present study, we focused our interest on the role of For example, it has been shown that cells bearing surface TGF-β (but not cells lacking this property) could activate the Notch signalling pathway leading to a tolerance state to respiratory Ags in the airway [4] . Notch signalling may also play a role in the differentiation of Treg cells as demonstrated in vitro or in vivo models [5] [6] [7] or in the modulation of TGF-β signalling [8, 9] . A recent report suggests that NICD interacts with pSmad3 enhancing its activity and TGF-β mediated effectors function of Treg cells. According to this, it has been recently shown that Notch1 activation enhances TGF-β signalling by increasing Smad translocation into the nucleus and its transactivation effect at promoter sites [9] .
On the other hand, and as shown here, Notch activation of effectors T cells increases their sensitivity to TGF-β. Finally, TGF-β is involved also on the generation and maintenance of adaptative Treg cells [8] . Collectively these data suggest that activated effectors T cells and Treg cells may be maintained at certain equilibrium by a regulatory loop induced by Notch activation.
Earlier studies established an interrelationship between TGF-β signalling and Notch signalling at the biochemical level. TGF-β signalling leads to a rapid upregulation of HES, a major target of Notch signalling in keratinocytes [16] , in neural stem cells and in myoblasts. There is clear evidence that stimulation of APC (Dendritic Cells) via Jagged enhances APC function from the point of view of maturation markers, cytokine production and differentiation effects on T cells [17] . This raises the question of whether DCs are exposed to Notch ligands in the microenvironments where they reside. In skin, keratinocytes constitutively express high levels of Jagged-1 [18] . Therefore, to prevent constitutive maturation of DCs, Notch signalling must be tightly regulated. It is conceivable that TGF-β inhibit the DCs maturation in physiological conditions. In the context of inflammation or infection for example [19, 20] , upregulation of Notch ligands on DCs, may modulate specific T cell responses in the presence of Treg cells.
As shown by our group and others in various culture systems, Notch ligands and engagement of different Notch family members may lead to distinct functional outcomes either in early or late stages of T cell development [21, 22] . Indeed, Notch proteins have been described as having a role in directing the differentiation of activated T cells to Th1 or Th2 T-cell lineages.
Interactions between DL-1 and Notch3 were described to influence the differentiation of activated CD4 + T cells, by promoting a Th1 cell phenotype [23, 24] while CD4 + T cells incubated with APCs expressing Jagged-1 adopted a Th2 cell-cell fate, producing IL-4 and IL-5 [25] . Taken together, these data implicated Jagged and DL ligands in the development of Cells were plated in media at a concentration of 1.25x10 5 to 5x10 5 cells per ml in a 96-well round-bottom plates coated with 1µg/ml of anti-CD3 (UCHT1) and 5µg/ml of Notch Ligand (DL-1-Fc, DL-4-Fc and Jagged-1-Fc are a generous Gift from Dr. Sakano).
Materials and methods
Cell culture
Suppression assay
A total of 2. In sensitizing asssays CD4 + CD25 -and CD4 + CD25 high were pre-incubated during 16 hours on coated Notch Ligand. Cells were also collected, washed and incubated alone or with Treg cells and stimulated as described above. Some experiments were performed in the presence of anti-TGF-β or IgG control (2.5 µg/ml). Gal plasmid diluted one-fourth was added as an internal control.
Real-time PCR
CD4
Statistical analysis
Results were expressed as means ± SE. Statistical significance was determined by two-tailed t test with a significance level of 0.05, using GraphStat software (GraphPad, San Diego,CA). 
